glp 1 side effects blindness Exploring the of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Can Ozempic-like Drugs Cause Blindness?

GLP-1 agonists have evolved considerably in the last two decades

Serious side effects are uncommon but possible

Synthetic agonists like semaglutide and tirzepatide are stable peptides that specifically activate the receptors of these hormones, amplifying their beneficial effects on glycemic control and weight management

The cases are illustrative rather than representative

Kooijman, S

Both treatment approaches resulted in a mean weight loss at 52 weeks, with oral semaglutide treatment resulting in a mean weight loss from baseline of 3.8 kg and 4.7 kg in the treatment-policy estimand and trial-product estimand analyses, respectively